epeleuton: Clinical Trials

3 trials of epeleuton, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow epeleuton: new trials by email Literature Review of epeleuton trials Research Report on epeleuton

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease
Epeleuton - Sickle Cell Disease
Phase 2CompletedAfimmune352024-01-102026-05-04
Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
DS102, Placebo - Hypertriglyceridemia, Type 2 Diabetes
Phase 2TerminatedAfimmune2332020-10-132023-06-12
Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD
Placebo capsules, Epeleuton - Non Alcoholic Fatty Liver Disease
Phase 2CompletedAfimmune962016-12-202022-10-12

Conditions studied

Anemia, Sickle Cell (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertriglyceridemia (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Sponsors

Afimmune (3)

Countries

Georgia (2)  ·  United States (2)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Latvia (1)  ·  Switzerland (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Markus Weissbach, MD (1)  ·  Philip Newsome, MBChB, FRCPE, Ph.D (1)

Results publications

PMID 32779505

NIH funding

2016 (1)